Risk Strategy in Non-Variceal Upper Gastrointestinal Bleeding

Non-variceal upper gastrointestinal bleeding

Management of Non-Variceal Upper Gastrointestinal Bleeding

Nonvariceal upper gastrointestinal bleeding is unique from variceal bleeding in terms of patient characteristics, management, rebleeding rates, and prognosis, and should be managed differently. The majority of nonvariceal upper gastrointestinal bleeds will not rebleed once treated successfully. The incidence is 80 to 90% of all upper gastrointestinal bleeds and the mortality is between 5 to 10%...

Acute endoscopic intervention in non-variceal upper gastrointestinal bleeding.

Upper gastrointestinal bleeding is one of the commonest emergencies encountered by general physicians. Once haemodynamic stability has been achieved, therapeutic endoscopy is vital in control and arrest of bleeding. Various methods are available and the evidence is reviewed as to the most optimal approach. Clinical parameters including timing of endoscopy, risk stratification, and predictors of...

Multidisciplinary management strategies for acute non-variceal upper gastrointestinal bleeding.

BACKGROUND The modern management of acute non-variceal upper gastrointestinal bleeding is centred on endoscopy, with recourse to interventional radiology and surgery in refractory cases. The appropriate use of intervention to optimize outcomes is reviewed. METHODS A literature search was undertaken of PubMed and the Cochrane Central Register of Controlled Trials between January 1990 and April...

Non-variceal Upper Gi Bleeding

Introduction In the United States, there are 250,000-300,000 hospital admissions and 15,000-30,000 deaths each year resulting from acute non-variceal upper gastrointestinal bleeding NVUGIB.1 Peptic ulcer disease is the most prevalent source of NVUGIB accounting for 50% of all cases. The incidence of NVUGIB ranges from 48-160 cases per 100,000 adults yearly. Recent data suggest the mortality fro...